文献速递免疫规划

TCR偏倚驱动疫苗诱导的显性CD8+ T细胞应答并可通过重定向靶向细胞目标

TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targets.
PubMed 文献 · Vaccine · 2025-10-14

对5名黄热病疫苗接种者接种后21天的黄热病特异性CD8+ T细胞进行单细胞TCR和mRNA测序,发现疫苗诱导的CD8+ T细胞应答具有多样性且表型重叠,TCR repertoire偏倚未导致抗原特异性独特表型;利用重组RoVER可将黄热病特异性CD8+ T细胞重定向至HIV-1感染的CD4+ T细胞和CD19+ B细胞并有效消除靶细胞。

要点

  • 黄热病疫苗诱导的CD8+ T细胞应答具有多样性,涵盖活化初始样、记忆和效应表型。
  • 尽管TCR repertoire存在偏倚,抗原特异性未促进接种后独特表型的产生。
  • 重组RoVER可将黄热病特异性CD8+ T细胞重定向并有效消除靶细胞。

核心结论

  • 黄热病疫苗诱导的CD8+ T细胞应答存在表型重叠,导致针对不同黄热病表位的CD8+ T细胞免疫冗余;利用重组RoVER可将黄热病特异性CD8+ T细胞重定向至其他靶细胞并有效消除靶细胞。

研究设计与样本

  • 对5名黄热病疫苗接种者接种后21天的黄热病特异性CD8+ T细胞进行单细胞TCR和mRNA测序,并使用HLA限制性双特异性T细胞衔接器RoVER进行重定向实验。

主要发现

  • 黄热病疫苗诱导了强健的CD8+ T细胞应答,黄热病特异性细胞具有多样性,涵盖活化初始样、记忆和效应表型。
  • 尽管TCR repertoire存在偏倚,抗原特异性未促进接种后独特表型的产生。
  • 使用重组RoVER可将黄热病特异性CD8+ T细胞重定向至包括HIV-1感染的CD4+ T细胞和CD19+ B细胞在内的靶细胞,导致有效的靶细胞消除。

临床怎么用

  • 作者认为本研究增进了对病毒感染细胞毒性T细胞应答及其对疫苗开发影响的理解,并支持开发针对个体HLA等位基因定制的个性化免疫疗法。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The yellow fever (YF) vaccine is known to elicit strong CD8+ T cell immune responses, predominantly targeting an HLA-A2-restricted immunodominant epitope within the NS4B protein. We aimed to characterize these cells and explore their functional utility when redirected to a target unrelated to YF. We performed single-cell TCR and mRNA sequencing on YF-specific CD8+ T cells from five vaccinated donors, 21 days post-vaccination to characterize their clonal diversity and transcriptional profiles. An HLA-restricted bispecific T cell engager, Redirector of Vaccine-induced Effector Responses (RoVER), was used to redirect YF-specific CD8+ T cells toward target cells including HIV-1-infected CD4+ T cells and CD19+ B cells. The vaccine elicited a robust CD8+ T cell response characterized by a diverse set of differentiated YF-specific cells spanning activated naïve-like, memory and effector phenotypes. Despite biases in the TCR repertoires, antigen-specificity did not promote the development of unique phenotypes following vaccination. Our findings suggest phenotypic overlap causing redundancy in CD8+ T cell immunity across YF epitopes. Using the recombinant RoVER, YF-specific CD8+ T cells could be redirected toward other target cells, leading to efficient target cell elimination. Together, this study enhances our understanding of the cytotoxic T cell response to viral infections and its implications for vaccine development, while also supporting the development of personalised immunotherapies tailored to individual HLA alleles.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Iversen EF, Rahimic AHF, Frattari GS, et al. TCR bias drives development of dominant vaccine-induced CD8+ T cell responses which can be redirected toward cellular targets. Vaccine. 2025. PMID: 41092800. doi:10.1016/j.vaccine.2025.127851

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。